Direct-to-Patient (DTP) Logistics in Clinical Trials
Direct-to-Patient (DTP) Logistics in Clinical Trials Direct-to-Patient (DTP) Logistics in Clinical Trials Introduction: The Rise of DTP Logistics Direct-to-Patient (DTP) logistics—delivering investigational medicinal products (IMPs) directly to patients’ homes—has emerged as a cornerstone of decentralized clinical trials (DCTs). For US sponsors, the FDA has increasingly focused on DTP oversight due to risks in chain of…
Read More “Direct-to-Patient (DTP) Logistics in Clinical Trials” »